Patents by Inventor Sandhya Ujire

Sandhya Ujire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR THE PREPARATION OF RANDOM POLYPEPTIDES AND EMPLOYING CIRCULAR DICHROISM AS A GUIDANCE TOOL FOR THE MANUFACTURE OF GLATIRAMER ACETATE
    Publication number: 20140288269
    Abstract: The present invention discloses novel process for the preparation of mixture of polypeptides comprising L-Glutamaic acid, L-Alanine, L-Tyrosine, and L-Lysine. by employing circular dichroism as a guidance tool.
    Type: Application
    Filed: October 26, 2012
    Publication date: September 25, 2014
    Inventors: Srinivas Pullela Venkata, Anand Khedkar, Nitin Sopanrao Patil, Sandhya Ujire, Amarnath Chatterjee, Ashwini Janakiraman
  • Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds
    Patent number: 6867306
    Abstract: The present invention discusses a novel process for the synthesis of [R-(R*,R*)]-2-(4-fluorophenyl)-B,D-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium, atorvastatin. The compound so prepared is useful as inhibitor of the HMG-CoA reductase and may thus be used as hypolipidemic and hypocholesterolemic agent.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: March 15, 2005
    Assignee: Biocon Limited
    Inventors: Sumitra Srinath, Joy Mathew, Sandhya Ujire, Madhavan Sridharan, Ganesh Sambasivam
  • Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds
    Publication number: 20040072893
    Abstract: The present invention discusses a novel process for the synthesis of [R-(R*,R*)]-2-(4-fluorophenyl)-B,D-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium, atorvastatin. The compound so prepared is useful as inhibitor of the enzyme HMG-CoA reductase and may thus be used as hypolipidemic and hypocholesterolemic agent.
    Type: Application
    Filed: July 16, 2003
    Publication date: April 15, 2004
    Inventors: Sumitra Srinath, Joy Mathew, Sandhya Ujire, Madhavan Sridharan, Ganesh Sambasivam